Fisher et al., 1967 - Google Patents
Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysisFisher et al., 1967
- Document ID
- 13439683955074023285
- Author
- Fisher S
- Fletcher A
- Alkjaersig N
- Sherry S
- Publication year
- Publication venue
- The Journal of Laboratory and Clinical Medicine
External Links
Snippet
Pathological plasma proteolysis (pathological" fibrinolysis") may occur in vivo as a consequence of plasminogen-plasmin enzyme system activity. In this disorder, a coagulation anomaly (defective fibrin polymerization) results from the presence, in plasma …
- 108010049003 Fibrinogen 0 title abstract description 125
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fisher et al. | Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis | |
Montgomery et al. | von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease. | |
Hawiger et al. | Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test | |
Ferro et al. | High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia | |
Bang et al. | Soluble fibrin complexes | |
Righetti et al. | Reutilization of amino acids in protein synthesis in HeLa cells | |
Kass et al. | Studies on the purification of antihemophilic factor (factor viii): i. precipitation of antihemophilic factor by concanavalin A | |
VanDeWater et al. | Analysis of elevated fibrin (ogen) degradation product levels in patients with liver disease | |
Niewiarowski et al. | Immunoassay of human platelet factor 4 (PF4, antiheparin factor) by radial immunodiffusion | |
Connaghan et al. | Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique | |
Gurewich et al. | A comparative study of precipitation and paracoagulation by protamine sulfate and ethanol gelation tests | |
Reeve et al. | Fibrinogen synthesis, distribution and degradation | |
Kisker et al. | Detection of intravascular coagulation | |
Andersen et al. | γG-antibody to human anti-hemophilic globulin (Factor VIII) | |
Lauf et al. | The M-antigen in HK and LK sheep red cell membranes | |
Zielinsky et al. | The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosis | |
Fishman et al. | Preparation and characterization of human intestinal alkaline phosphatase antigens | |
Cassidy et al. | Characterization of detergent-solubilized iodine-125-labeled. alpha.-toxin bound to rabbit erythrocytes and mouse diaphragm muscle | |
Levine et al. | Human platelet factor 4: preparation from outdated platelet concentrates and application in cerebral vascular disease | |
Sanchez-Avalos et al. | Degradation of fibrinogen by proteolytic enzymes | |
Franks et al. | Fibrinogen and fibrinogen-related peptides in cancer | |
Kisker et al. | A method for measurement of fibrin monomer with the use of an immune precipitate of fibrinogen | |
Cummings et al. | Atypical γ1A-globulin with the electrophoretic properties of an α2-globulin occurring in multiple myeloma | |
Plow et al. | Unique immunochemical features and intracellular stability of platelet fibrinogen | |
Rudbach et al. | Alteration and restoration of endotoxin activity after complexing with plasma proteins |